DESCRIPTIVE ANALYSIS OF THE DIRECT COSTS OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE MEXICAN SETTING

被引:0
|
作者
Pizarro, M. [1 ]
Soto, H. [2 ]
Carbajal, A. [3 ]
机构
[1] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico
[2] Iteliness Consulting, Mexico City, DF, Mexico
[3] Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
关键词
D O I
10.1016/j.jval.2012.08.1946
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A549 / A549
页数:1
相关论文
共 50 条
  • [31] Resistance Training in Relapsing-Remitting Multiple Sclerosis
    Dalgas, U.
    Kant, M.
    Stenager, E.
    AKTUELLE NEUROLOGIE, 2010, 37 (05) : 213 - 218
  • [32] Cognitive Resilience in Relapsing-Remitting Multiple Sclerosis
    Achiron, Anat
    Harel, Yermi
    Lavie, Mor
    Simon, Ely S.
    Doniger, Glen M.
    NEUROLOGY, 2010, 74 (09) : A162 - A162
  • [33] Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
    Omerzu, T.
    Magdic, J.
    Hojs, R.
    Fabjan, T. Hojs
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 376 - 377
  • [34] Disease severity and health care costs of relapsing-remitting multiple sclerosis in Portugal
    Mateus, C
    Pereira, J
    VALUE IN HEALTH, 2005, 8 (06) : A134 - A134
  • [35] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [36] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [37] A CASE OF RELAPSING-REMITTING TUMEFACTIVE MULTIPLE SCLEROSIS
    Turnbull, H.
    Karsan, N.
    Hogg, F.
    Pereira, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
  • [38] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [39] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [40] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648